Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-11

FDA Approved: SAPROPTERIN DIHYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s sapropterin dihydrochloride via an original application, adding a new approved product for management of phenylket…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sapropterin dihydrochloride (Sapropterin dihydrochloride)

Snippet

ORIG AP for SAPROPTERIN DIHYDROCHLORIDE (SAPROPTERIN DIHYDROCHLORIDE)